Global Cell and Gene Therapy Manufacturing Services Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Gene therapy aims to treat disorders by replacing or introducing genes into cells— either inside the body (in vivo) or outside of the body (ex vivo).
LPI (LP Information)' newest research report, the “Cell and Gene Therapy Manufacturing Services Industry Forecast” looks at past sales and reviews total world Cell and Gene Therapy Manufacturing Services sales in 2022, providing a comprehensive analysis by region and market sector of projected Cell and Gene Therapy Manufacturing Services sales for 2023 through 2029. With Cell and Gene Therapy Manufacturing Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cell and Gene Therapy Manufacturing Services industry.
This Insight Report provides a comprehensive analysis of the global Cell and Gene Therapy Manufacturing Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cell and Gene Therapy Manufacturing Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cell and Gene Therapy Manufacturing Services market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cell and Gene Therapy Manufacturing Services and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cell and Gene Therapy Manufacturing Services.
The global Cell and Gene Therapy Manufacturing Services market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Cell and Gene Therapy Manufacturing Services is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Cell and Gene Therapy Manufacturing Services is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Cell and Gene Therapy Manufacturing Services is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Cell and Gene Therapy Manufacturing Services players cover Thermo Fisher Scientific, Merck KGaA, Charles River Laboratories, Lonza, Catalent, WuXi AppTec, Takara Bio Inc, Nikon Corporation and FUJIFILM Holdings Corporation, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Cell and Gene Therapy Manufacturing Services market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Gene therapy aims to treat disorders by replacing or introducing genes into cells— either inside the body (in vivo) or outside of the body (ex vivo).
LPI (LP Information)' newest research report, the “Cell and Gene Therapy Manufacturing Services Industry Forecast” looks at past sales and reviews total world Cell and Gene Therapy Manufacturing Services sales in 2022, providing a comprehensive analysis by region and market sector of projected Cell and Gene Therapy Manufacturing Services sales for 2023 through 2029. With Cell and Gene Therapy Manufacturing Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cell and Gene Therapy Manufacturing Services industry.
This Insight Report provides a comprehensive analysis of the global Cell and Gene Therapy Manufacturing Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cell and Gene Therapy Manufacturing Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cell and Gene Therapy Manufacturing Services market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cell and Gene Therapy Manufacturing Services and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cell and Gene Therapy Manufacturing Services.
The global Cell and Gene Therapy Manufacturing Services market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Cell and Gene Therapy Manufacturing Services is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Cell and Gene Therapy Manufacturing Services is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Cell and Gene Therapy Manufacturing Services is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Cell and Gene Therapy Manufacturing Services players cover Thermo Fisher Scientific, Merck KGaA, Charles River Laboratories, Lonza, Catalent, WuXi AppTec, Takara Bio Inc, Nikon Corporation and FUJIFILM Holdings Corporation, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Cell and Gene Therapy Manufacturing Services market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- By Cell Therapy
- Allogeneic
- Autologous
- Viral Vector
- By Gene Therapy
- Non-viral Vector
- Oligonucleotides
- Viral Vector
- Oncology Diseases
- Cardiovascular Diseases
- Orthopedic Diseases
- Ophthalmology Diseases
- Infectious Diseases
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Thermo Fisher Scientific
- Merck KGaA
- Charles River Laboratories
- Lonza
- Catalent
- WuXi AppTec
- Takara Bio Inc
- Nikon Corporation
- FUJIFILM Holdings Corporation
- F. Hoffmann-La Roche
- Oxford Biomedica Plc
- Cell and Gene Therapy Catapult
- The Discovery Labs LLC
- RoslinCT
- JRS PHARMA
- FinVector
- ABL
- Resilience
- BioCentriq
- Porton Biopharma Limited
- Andelyn Biosciences
- Commercializing Living Therapies
- Vibalogics
- Anemocyte Srl
- ElevateBio
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Cell and Gene Therapy Manufacturing Services Market Size 2018-2029
2.1.2 Cell and Gene Therapy Manufacturing Services Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Cell and Gene Therapy Manufacturing Services Segment by Type
2.2.1 Allogeneic
2.2.2 Autologous
2.2.3 Viral Vector
2.3 Cell and Gene Therapy Manufacturing Services Market Size by Type
2.3.1 Cell and Gene Therapy Manufacturing Services Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Cell and Gene Therapy Manufacturing Services Market Size Market Share by Type (2018-2023)
2.4 Cell and Gene Therapy Manufacturing Services Segment by Application
2.4.1 Oncology Diseases
2.4.2 Cardiovascular Diseases
2.4.3 Orthopedic Diseases
2.4.4 Ophthalmology Diseases
2.4.5 Infectious Diseases
2.4.6 Others
2.5 Cell and Gene Therapy Manufacturing Services Market Size by Application
2.5.1 Cell and Gene Therapy Manufacturing Services Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Cell and Gene Therapy Manufacturing Services Market Size Market Share by Application (2018-2023)
3 CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET SIZE BY PLAYER
3.1 Cell and Gene Therapy Manufacturing Services Market Size Market Share by Players
3.1.1 Global Cell and Gene Therapy Manufacturing Services Revenue by Players (2018-2023)
3.1.2 Global Cell and Gene Therapy Manufacturing Services Revenue Market Share by Players (2018-2023)
3.2 Global Cell and Gene Therapy Manufacturing Services Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CELL AND GENE THERAPY MANUFACTURING SERVICES BY REGIONS
4.1 Cell and Gene Therapy Manufacturing Services Market Size by Regions (2018-2023)
4.2 Americas Cell and Gene Therapy Manufacturing Services Market Size Growth (2018-2023)
4.3 APAC Cell and Gene Therapy Manufacturing Services Market Size Growth (2018-2023)
4.4 Europe Cell and Gene Therapy Manufacturing Services Market Size Growth (2018-2023)
4.5 Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Cell and Gene Therapy Manufacturing Services Market Size by Country (2018-2023)
5.2 Americas Cell and Gene Therapy Manufacturing Services Market Size by Type (2018-2023)
5.3 Americas Cell and Gene Therapy Manufacturing Services Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cell and Gene Therapy Manufacturing Services Market Size by Region (2018-2023)
6.2 APAC Cell and Gene Therapy Manufacturing Services Market Size by Type (2018-2023)
6.3 APAC Cell and Gene Therapy Manufacturing Services Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Cell and Gene Therapy Manufacturing Services by Country (2018-2023)
7.2 Europe Cell and Gene Therapy Manufacturing Services Market Size by Type (2018-2023)
7.3 Europe Cell and Gene Therapy Manufacturing Services Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Cell and Gene Therapy Manufacturing Services by Region (2018-2023)
8.2 Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Size by Type (2018-2023)
8.3 Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET FORECAST
10.1 Global Cell and Gene Therapy Manufacturing Services Forecast by Regions (2024-2029)
10.1.1 Global Cell and Gene Therapy Manufacturing Services Forecast by Regions (2024-2029)
10.1.2 Americas Cell and Gene Therapy Manufacturing Services Forecast
10.1.3 APAC Cell and Gene Therapy Manufacturing Services Forecast
10.1.4 Europe Cell and Gene Therapy Manufacturing Services Forecast
10.1.5 Middle East & Africa Cell and Gene Therapy Manufacturing Services Forecast
10.2 Americas Cell and Gene Therapy Manufacturing Services Forecast by Country (2024-2029)
10.2.1 United States Cell and Gene Therapy Manufacturing Services Market Forecast
10.2.2 Canada Cell and Gene Therapy Manufacturing Services Market Forecast
10.2.3 Mexico Cell and Gene Therapy Manufacturing Services Market Forecast
10.2.4 Brazil Cell and Gene Therapy Manufacturing Services Market Forecast
10.3 APAC Cell and Gene Therapy Manufacturing Services Forecast by Region (2024-2029)
10.3.1 China Cell and Gene Therapy Manufacturing Services Market Forecast
10.3.2 Japan Cell and Gene Therapy Manufacturing Services Market Forecast
10.3.3 Korea Cell and Gene Therapy Manufacturing Services Market Forecast
10.3.4 Southeast Asia Cell and Gene Therapy Manufacturing Services Market Forecast
10.3.5 India Cell and Gene Therapy Manufacturing Services Market Forecast
10.3.6 Australia Cell and Gene Therapy Manufacturing Services Market Forecast
10.4 Europe Cell and Gene Therapy Manufacturing Services Forecast by Country (2024-2029)
10.4.1 Germany Cell and Gene Therapy Manufacturing Services Market Forecast
10.4.2 France Cell and Gene Therapy Manufacturing Services Market Forecast
10.4.3 UK Cell and Gene Therapy Manufacturing Services Market Forecast
10.4.4 Italy Cell and Gene Therapy Manufacturing Services Market Forecast
10.4.5 Russia Cell and Gene Therapy Manufacturing Services Market Forecast
10.5 Middle East & Africa Cell and Gene Therapy Manufacturing Services Forecast by Region (2024-2029)
10.5.1 Egypt Cell and Gene Therapy Manufacturing Services Market Forecast
10.5.2 South Africa Cell and Gene Therapy Manufacturing Services Market Forecast
10.5.3 Israel Cell and Gene Therapy Manufacturing Services Market Forecast
10.5.4 Turkey Cell and Gene Therapy Manufacturing Services Market Forecast
10.5.5 GCC Countries Cell and Gene Therapy Manufacturing Services Market Forecast
10.6 Global Cell and Gene Therapy Manufacturing Services Forecast by Type (2024-2029)
10.7 Global Cell and Gene Therapy Manufacturing Services Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Information
11.1.2 Thermo Fisher Scientific Cell and Gene Therapy Manufacturing Services Product Offered
11.1.3 Thermo Fisher Scientific Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Thermo Fisher Scientific Main Business Overview
11.1.5 Thermo Fisher Scientific Latest Developments
11.2 Merck KGaA
11.2.1 Merck KGaA Company Information
11.2.2 Merck KGaA Cell and Gene Therapy Manufacturing Services Product Offered
11.2.3 Merck KGaA Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Merck KGaA Main Business Overview
11.2.5 Merck KGaA Latest Developments
11.3 Charles River Laboratories
11.3.1 Charles River Laboratories Company Information
11.3.2 Charles River Laboratories Cell and Gene Therapy Manufacturing Services Product Offered
11.3.3 Charles River Laboratories Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Charles River Laboratories Main Business Overview
11.3.5 Charles River Laboratories Latest Developments
11.4 Lonza
11.4.1 Lonza Company Information
11.4.2 Lonza Cell and Gene Therapy Manufacturing Services Product Offered
11.4.3 Lonza Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Lonza Main Business Overview
11.4.5 Lonza Latest Developments
11.5 Catalent
11.5.1 Catalent Company Information
11.5.2 Catalent Cell and Gene Therapy Manufacturing Services Product Offered
11.5.3 Catalent Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Catalent Main Business Overview
11.5.5 Catalent Latest Developments
11.6 WuXi AppTec
11.6.1 WuXi AppTec Company Information
11.6.2 WuXi AppTec Cell and Gene Therapy Manufacturing Services Product Offered
11.6.3 WuXi AppTec Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 WuXi AppTec Main Business Overview
11.6.5 WuXi AppTec Latest Developments
11.7 Takara Bio Inc
11.7.1 Takara Bio Inc Company Information
11.7.2 Takara Bio Inc Cell and Gene Therapy Manufacturing Services Product Offered
11.7.3 Takara Bio Inc Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Takara Bio Inc Main Business Overview
11.7.5 Takara Bio Inc Latest Developments
11.8 Nikon Corporation
11.8.1 Nikon Corporation Company Information
11.8.2 Nikon Corporation Cell and Gene Therapy Manufacturing Services Product Offered
11.8.3 Nikon Corporation Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Nikon Corporation Main Business Overview
11.8.5 Nikon Corporation Latest Developments
11.9 FUJIFILM Holdings Corporation
11.9.1 FUJIFILM Holdings Corporation Company Information
11.9.2 FUJIFILM Holdings Corporation Cell and Gene Therapy Manufacturing Services Product Offered
11.9.3 FUJIFILM Holdings Corporation Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 FUJIFILM Holdings Corporation Main Business Overview
11.9.5 FUJIFILM Holdings Corporation Latest Developments
11.10 F. Hoffmann-La Roche
11.10.1 F. Hoffmann-La Roche Company Information
11.10.2 F. Hoffmann-La Roche Cell and Gene Therapy Manufacturing Services Product Offered
11.10.3 F. Hoffmann-La Roche Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 F. Hoffmann-La Roche Main Business Overview
11.10.5 F. Hoffmann-La Roche Latest Developments
11.11 Oxford Biomedica Plc
11.11.1 Oxford Biomedica Plc Company Information
11.11.2 Oxford Biomedica Plc Cell and Gene Therapy Manufacturing Services Product Offered
11.11.3 Oxford Biomedica Plc Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Oxford Biomedica Plc Main Business Overview
11.11.5 Oxford Biomedica Plc Latest Developments
11.12 Cell and Gene Therapy Catapult
11.12.1 Cell and Gene Therapy Catapult Company Information
11.12.2 Cell and Gene Therapy Catapult Cell and Gene Therapy Manufacturing Services Product Offered
11.12.3 Cell and Gene Therapy Catapult Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Cell and Gene Therapy Catapult Main Business Overview
11.12.5 Cell and Gene Therapy Catapult Latest Developments
11.13 The Discovery Labs LLC
11.13.1 The Discovery Labs LLC Company Information
11.13.2 The Discovery Labs LLC Cell and Gene Therapy Manufacturing Services Product Offered
11.13.3 The Discovery Labs LLC Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 The Discovery Labs LLC Main Business Overview
11.13.5 The Discovery Labs LLC Latest Developments
11.14 RoslinCT
11.14.1 RoslinCT Company Information
11.14.2 RoslinCT Cell and Gene Therapy Manufacturing Services Product Offered
11.14.3 RoslinCT Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 RoslinCT Main Business Overview
11.14.5 RoslinCT Latest Developments
11.15 JRS PHARMA
11.15.1 JRS PHARMA Company Information
11.15.2 JRS PHARMA Cell and Gene Therapy Manufacturing Services Product Offered
11.15.3 JRS PHARMA Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 JRS PHARMA Main Business Overview
11.15.5 JRS PHARMA Latest Developments
11.16 FinVector
11.16.1 FinVector Company Information
11.16.2 FinVector Cell and Gene Therapy Manufacturing Services Product Offered
11.16.3 FinVector Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 FinVector Main Business Overview
11.16.5 FinVector Latest Developments
11.17 ABL
11.17.1 ABL Company Information
11.17.2 ABL Cell and Gene Therapy Manufacturing Services Product Offered
11.17.3 ABL Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
11.17.4 ABL Main Business Overview
11.17.5 ABL Latest Developments
11.18 Resilience
11.18.1 Resilience Company Information
11.18.2 Resilience Cell and Gene Therapy Manufacturing Services Product Offered
11.18.3 Resilience Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
11.18.4 Resilience Main Business Overview
11.18.5 Resilience Latest Developments
11.19 BioCentriq
11.19.1 BioCentriq Company Information
11.19.2 BioCentriq Cell and Gene Therapy Manufacturing Services Product Offered
11.19.3 BioCentriq Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
11.19.4 BioCentriq Main Business Overview
11.19.5 BioCentriq Latest Developments
11.20 Porton Biopharma Limited
11.20.1 Porton Biopharma Limited Company Information
11.20.2 Porton Biopharma Limited Cell and Gene Therapy Manufacturing Services Product Offered
11.20.3 Porton Biopharma Limited Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
11.20.4 Porton Biopharma Limited Main Business Overview
11.20.5 Porton Biopharma Limited Latest Developments
11.21 Andelyn Biosciences
11.21.1 Andelyn Biosciences Company Information
11.21.2 Andelyn Biosciences Cell and Gene Therapy Manufacturing Services Product Offered
11.21.3 Andelyn Biosciences Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
11.21.4 Andelyn Biosciences Main Business Overview
11.21.5 Andelyn Biosciences Latest Developments
11.22 Commercializing Living Therapies
11.22.1 Commercializing Living Therapies Company Information
11.22.2 Commercializing Living Therapies Cell and Gene Therapy Manufacturing Services Product Offered
11.22.3 Commercializing Living Therapies Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
11.22.4 Commercializing Living Therapies Main Business Overview
11.22.5 Commercializing Living Therapies Latest Developments
11.23 Vibalogics
11.23.1 Vibalogics Company Information
11.23.2 Vibalogics Cell and Gene Therapy Manufacturing Services Product Offered
11.23.3 Vibalogics Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
11.23.4 Vibalogics Main Business Overview
11.23.5 Vibalogics Latest Developments
11.24 Anemocyte Srl
11.24.1 Anemocyte Srl Company Information
11.24.2 Anemocyte Srl Cell and Gene Therapy Manufacturing Services Product Offered
11.24.3 Anemocyte Srl Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
11.24.4 Anemocyte Srl Main Business Overview
11.24.5 Anemocyte Srl Latest Developments
11.25 ElevateBio
11.25.1 ElevateBio Company Information
11.25.2 ElevateBio Cell and Gene Therapy Manufacturing Services Product Offered
11.25.3 ElevateBio Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
11.25.4 ElevateBio Main Business Overview
11.25.5 ElevateBio Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Cell and Gene Therapy Manufacturing Services Market Size 2018-2029
2.1.2 Cell and Gene Therapy Manufacturing Services Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Cell and Gene Therapy Manufacturing Services Segment by Type
2.2.1 Allogeneic
2.2.2 Autologous
2.2.3 Viral Vector
2.3 Cell and Gene Therapy Manufacturing Services Market Size by Type
2.3.1 Cell and Gene Therapy Manufacturing Services Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Cell and Gene Therapy Manufacturing Services Market Size Market Share by Type (2018-2023)
2.4 Cell and Gene Therapy Manufacturing Services Segment by Application
2.4.1 Oncology Diseases
2.4.2 Cardiovascular Diseases
2.4.3 Orthopedic Diseases
2.4.4 Ophthalmology Diseases
2.4.5 Infectious Diseases
2.4.6 Others
2.5 Cell and Gene Therapy Manufacturing Services Market Size by Application
2.5.1 Cell and Gene Therapy Manufacturing Services Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Cell and Gene Therapy Manufacturing Services Market Size Market Share by Application (2018-2023)
3 CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET SIZE BY PLAYER
3.1 Cell and Gene Therapy Manufacturing Services Market Size Market Share by Players
3.1.1 Global Cell and Gene Therapy Manufacturing Services Revenue by Players (2018-2023)
3.1.2 Global Cell and Gene Therapy Manufacturing Services Revenue Market Share by Players (2018-2023)
3.2 Global Cell and Gene Therapy Manufacturing Services Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CELL AND GENE THERAPY MANUFACTURING SERVICES BY REGIONS
4.1 Cell and Gene Therapy Manufacturing Services Market Size by Regions (2018-2023)
4.2 Americas Cell and Gene Therapy Manufacturing Services Market Size Growth (2018-2023)
4.3 APAC Cell and Gene Therapy Manufacturing Services Market Size Growth (2018-2023)
4.4 Europe Cell and Gene Therapy Manufacturing Services Market Size Growth (2018-2023)
4.5 Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Cell and Gene Therapy Manufacturing Services Market Size by Country (2018-2023)
5.2 Americas Cell and Gene Therapy Manufacturing Services Market Size by Type (2018-2023)
5.3 Americas Cell and Gene Therapy Manufacturing Services Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cell and Gene Therapy Manufacturing Services Market Size by Region (2018-2023)
6.2 APAC Cell and Gene Therapy Manufacturing Services Market Size by Type (2018-2023)
6.3 APAC Cell and Gene Therapy Manufacturing Services Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Cell and Gene Therapy Manufacturing Services by Country (2018-2023)
7.2 Europe Cell and Gene Therapy Manufacturing Services Market Size by Type (2018-2023)
7.3 Europe Cell and Gene Therapy Manufacturing Services Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Cell and Gene Therapy Manufacturing Services by Region (2018-2023)
8.2 Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Size by Type (2018-2023)
8.3 Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET FORECAST
10.1 Global Cell and Gene Therapy Manufacturing Services Forecast by Regions (2024-2029)
10.1.1 Global Cell and Gene Therapy Manufacturing Services Forecast by Regions (2024-2029)
10.1.2 Americas Cell and Gene Therapy Manufacturing Services Forecast
10.1.3 APAC Cell and Gene Therapy Manufacturing Services Forecast
10.1.4 Europe Cell and Gene Therapy Manufacturing Services Forecast
10.1.5 Middle East & Africa Cell and Gene Therapy Manufacturing Services Forecast
10.2 Americas Cell and Gene Therapy Manufacturing Services Forecast by Country (2024-2029)
10.2.1 United States Cell and Gene Therapy Manufacturing Services Market Forecast
10.2.2 Canada Cell and Gene Therapy Manufacturing Services Market Forecast
10.2.3 Mexico Cell and Gene Therapy Manufacturing Services Market Forecast
10.2.4 Brazil Cell and Gene Therapy Manufacturing Services Market Forecast
10.3 APAC Cell and Gene Therapy Manufacturing Services Forecast by Region (2024-2029)
10.3.1 China Cell and Gene Therapy Manufacturing Services Market Forecast
10.3.2 Japan Cell and Gene Therapy Manufacturing Services Market Forecast
10.3.3 Korea Cell and Gene Therapy Manufacturing Services Market Forecast
10.3.4 Southeast Asia Cell and Gene Therapy Manufacturing Services Market Forecast
10.3.5 India Cell and Gene Therapy Manufacturing Services Market Forecast
10.3.6 Australia Cell and Gene Therapy Manufacturing Services Market Forecast
10.4 Europe Cell and Gene Therapy Manufacturing Services Forecast by Country (2024-2029)
10.4.1 Germany Cell and Gene Therapy Manufacturing Services Market Forecast
10.4.2 France Cell and Gene Therapy Manufacturing Services Market Forecast
10.4.3 UK Cell and Gene Therapy Manufacturing Services Market Forecast
10.4.4 Italy Cell and Gene Therapy Manufacturing Services Market Forecast
10.4.5 Russia Cell and Gene Therapy Manufacturing Services Market Forecast
10.5 Middle East & Africa Cell and Gene Therapy Manufacturing Services Forecast by Region (2024-2029)
10.5.1 Egypt Cell and Gene Therapy Manufacturing Services Market Forecast
10.5.2 South Africa Cell and Gene Therapy Manufacturing Services Market Forecast
10.5.3 Israel Cell and Gene Therapy Manufacturing Services Market Forecast
10.5.4 Turkey Cell and Gene Therapy Manufacturing Services Market Forecast
10.5.5 GCC Countries Cell and Gene Therapy Manufacturing Services Market Forecast
10.6 Global Cell and Gene Therapy Manufacturing Services Forecast by Type (2024-2029)
10.7 Global Cell and Gene Therapy Manufacturing Services Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Information
11.1.2 Thermo Fisher Scientific Cell and Gene Therapy Manufacturing Services Product Offered
11.1.3 Thermo Fisher Scientific Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Thermo Fisher Scientific Main Business Overview
11.1.5 Thermo Fisher Scientific Latest Developments
11.2 Merck KGaA
11.2.1 Merck KGaA Company Information
11.2.2 Merck KGaA Cell and Gene Therapy Manufacturing Services Product Offered
11.2.3 Merck KGaA Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Merck KGaA Main Business Overview
11.2.5 Merck KGaA Latest Developments
11.3 Charles River Laboratories
11.3.1 Charles River Laboratories Company Information
11.3.2 Charles River Laboratories Cell and Gene Therapy Manufacturing Services Product Offered
11.3.3 Charles River Laboratories Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Charles River Laboratories Main Business Overview
11.3.5 Charles River Laboratories Latest Developments
11.4 Lonza
11.4.1 Lonza Company Information
11.4.2 Lonza Cell and Gene Therapy Manufacturing Services Product Offered
11.4.3 Lonza Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Lonza Main Business Overview
11.4.5 Lonza Latest Developments
11.5 Catalent
11.5.1 Catalent Company Information
11.5.2 Catalent Cell and Gene Therapy Manufacturing Services Product Offered
11.5.3 Catalent Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Catalent Main Business Overview
11.5.5 Catalent Latest Developments
11.6 WuXi AppTec
11.6.1 WuXi AppTec Company Information
11.6.2 WuXi AppTec Cell and Gene Therapy Manufacturing Services Product Offered
11.6.3 WuXi AppTec Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 WuXi AppTec Main Business Overview
11.6.5 WuXi AppTec Latest Developments
11.7 Takara Bio Inc
11.7.1 Takara Bio Inc Company Information
11.7.2 Takara Bio Inc Cell and Gene Therapy Manufacturing Services Product Offered
11.7.3 Takara Bio Inc Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Takara Bio Inc Main Business Overview
11.7.5 Takara Bio Inc Latest Developments
11.8 Nikon Corporation
11.8.1 Nikon Corporation Company Information
11.8.2 Nikon Corporation Cell and Gene Therapy Manufacturing Services Product Offered
11.8.3 Nikon Corporation Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Nikon Corporation Main Business Overview
11.8.5 Nikon Corporation Latest Developments
11.9 FUJIFILM Holdings Corporation
11.9.1 FUJIFILM Holdings Corporation Company Information
11.9.2 FUJIFILM Holdings Corporation Cell and Gene Therapy Manufacturing Services Product Offered
11.9.3 FUJIFILM Holdings Corporation Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 FUJIFILM Holdings Corporation Main Business Overview
11.9.5 FUJIFILM Holdings Corporation Latest Developments
11.10 F. Hoffmann-La Roche
11.10.1 F. Hoffmann-La Roche Company Information
11.10.2 F. Hoffmann-La Roche Cell and Gene Therapy Manufacturing Services Product Offered
11.10.3 F. Hoffmann-La Roche Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 F. Hoffmann-La Roche Main Business Overview
11.10.5 F. Hoffmann-La Roche Latest Developments
11.11 Oxford Biomedica Plc
11.11.1 Oxford Biomedica Plc Company Information
11.11.2 Oxford Biomedica Plc Cell and Gene Therapy Manufacturing Services Product Offered
11.11.3 Oxford Biomedica Plc Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Oxford Biomedica Plc Main Business Overview
11.11.5 Oxford Biomedica Plc Latest Developments
11.12 Cell and Gene Therapy Catapult
11.12.1 Cell and Gene Therapy Catapult Company Information
11.12.2 Cell and Gene Therapy Catapult Cell and Gene Therapy Manufacturing Services Product Offered
11.12.3 Cell and Gene Therapy Catapult Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Cell and Gene Therapy Catapult Main Business Overview
11.12.5 Cell and Gene Therapy Catapult Latest Developments
11.13 The Discovery Labs LLC
11.13.1 The Discovery Labs LLC Company Information
11.13.2 The Discovery Labs LLC Cell and Gene Therapy Manufacturing Services Product Offered
11.13.3 The Discovery Labs LLC Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 The Discovery Labs LLC Main Business Overview
11.13.5 The Discovery Labs LLC Latest Developments
11.14 RoslinCT
11.14.1 RoslinCT Company Information
11.14.2 RoslinCT Cell and Gene Therapy Manufacturing Services Product Offered
11.14.3 RoslinCT Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 RoslinCT Main Business Overview
11.14.5 RoslinCT Latest Developments
11.15 JRS PHARMA
11.15.1 JRS PHARMA Company Information
11.15.2 JRS PHARMA Cell and Gene Therapy Manufacturing Services Product Offered
11.15.3 JRS PHARMA Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 JRS PHARMA Main Business Overview
11.15.5 JRS PHARMA Latest Developments
11.16 FinVector
11.16.1 FinVector Company Information
11.16.2 FinVector Cell and Gene Therapy Manufacturing Services Product Offered
11.16.3 FinVector Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 FinVector Main Business Overview
11.16.5 FinVector Latest Developments
11.17 ABL
11.17.1 ABL Company Information
11.17.2 ABL Cell and Gene Therapy Manufacturing Services Product Offered
11.17.3 ABL Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
11.17.4 ABL Main Business Overview
11.17.5 ABL Latest Developments
11.18 Resilience
11.18.1 Resilience Company Information
11.18.2 Resilience Cell and Gene Therapy Manufacturing Services Product Offered
11.18.3 Resilience Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
11.18.4 Resilience Main Business Overview
11.18.5 Resilience Latest Developments
11.19 BioCentriq
11.19.1 BioCentriq Company Information
11.19.2 BioCentriq Cell and Gene Therapy Manufacturing Services Product Offered
11.19.3 BioCentriq Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
11.19.4 BioCentriq Main Business Overview
11.19.5 BioCentriq Latest Developments
11.20 Porton Biopharma Limited
11.20.1 Porton Biopharma Limited Company Information
11.20.2 Porton Biopharma Limited Cell and Gene Therapy Manufacturing Services Product Offered
11.20.3 Porton Biopharma Limited Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
11.20.4 Porton Biopharma Limited Main Business Overview
11.20.5 Porton Biopharma Limited Latest Developments
11.21 Andelyn Biosciences
11.21.1 Andelyn Biosciences Company Information
11.21.2 Andelyn Biosciences Cell and Gene Therapy Manufacturing Services Product Offered
11.21.3 Andelyn Biosciences Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
11.21.4 Andelyn Biosciences Main Business Overview
11.21.5 Andelyn Biosciences Latest Developments
11.22 Commercializing Living Therapies
11.22.1 Commercializing Living Therapies Company Information
11.22.2 Commercializing Living Therapies Cell and Gene Therapy Manufacturing Services Product Offered
11.22.3 Commercializing Living Therapies Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
11.22.4 Commercializing Living Therapies Main Business Overview
11.22.5 Commercializing Living Therapies Latest Developments
11.23 Vibalogics
11.23.1 Vibalogics Company Information
11.23.2 Vibalogics Cell and Gene Therapy Manufacturing Services Product Offered
11.23.3 Vibalogics Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
11.23.4 Vibalogics Main Business Overview
11.23.5 Vibalogics Latest Developments
11.24 Anemocyte Srl
11.24.1 Anemocyte Srl Company Information
11.24.2 Anemocyte Srl Cell and Gene Therapy Manufacturing Services Product Offered
11.24.3 Anemocyte Srl Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
11.24.4 Anemocyte Srl Main Business Overview
11.24.5 Anemocyte Srl Latest Developments
11.25 ElevateBio
11.25.1 ElevateBio Company Information
11.25.2 ElevateBio Cell and Gene Therapy Manufacturing Services Product Offered
11.25.3 ElevateBio Cell and Gene Therapy Manufacturing Services Revenue, Gross Margin and Market Share (2018-2023)
11.25.4 ElevateBio Main Business Overview
11.25.5 ElevateBio Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Cell and Gene Therapy Manufacturing Services Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Allogeneic
Table 3. Major Players of Autologous
Table 4. Major Players of Viral Vector
Table 5. Cell and Gene Therapy Manufacturing Services Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 6. Global Cell and Gene Therapy Manufacturing Services Market Size by Type (2018-2023) & ($ Millions)
Table 7. Global Cell and Gene Therapy Manufacturing Services Market Size Market Share by Type (2018-2023)
Table 8. Cell and Gene Therapy Manufacturing Services Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global Cell and Gene Therapy Manufacturing Services Market Size by Application (2018-2023) & ($ Millions)
Table 10. Global Cell and Gene Therapy Manufacturing Services Market Size Market Share by Application (2018-2023)
Table 11. Global Cell and Gene Therapy Manufacturing Services Revenue by Players (2018-2023) & ($ Millions)
Table 12. Global Cell and Gene Therapy Manufacturing Services Revenue Market Share by Player (2018-2023)
Table 13. Cell and Gene Therapy Manufacturing Services Key Players Head office and Products Offered
Table 14. Cell and Gene Therapy Manufacturing Services Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Cell and Gene Therapy Manufacturing Services Market Size by Regions 2018-2023 & ($ Millions)
Table 18. Global Cell and Gene Therapy Manufacturing Services Market Size Market Share by Regions (2018-2023)
Table 19. Global Cell and Gene Therapy Manufacturing Services Revenue by Country/Region (2018-2023) & ($ millions)
Table 20. Global Cell and Gene Therapy Manufacturing Services Revenue Market Share by Country/Region (2018-2023)
Table 21. Americas Cell and Gene Therapy Manufacturing Services Market Size by Country (2018-2023) & ($ Millions)
Table 22. Americas Cell and Gene Therapy Manufacturing Services Market Size Market Share by Country (2018-2023)
Table 23. Americas Cell and Gene Therapy Manufacturing Services Market Size by Type (2018-2023) & ($ Millions)
Table 24. Americas Cell and Gene Therapy Manufacturing Services Market Size Market Share by Type (2018-2023)
Table 25. Americas Cell and Gene Therapy Manufacturing Services Market Size by Application (2018-2023) & ($ Millions)
Table 26. Americas Cell and Gene Therapy Manufacturing Services Market Size Market Share by Application (2018-2023)
Table 27. APAC Cell and Gene Therapy Manufacturing Services Market Size by Region (2018-2023) & ($ Millions)
Table 28. APAC Cell and Gene Therapy Manufacturing Services Market Size Market Share by Region (2018-2023)
Table 29. APAC Cell and Gene Therapy Manufacturing Services Market Size by Type (2018-2023) & ($ Millions)
Table 30. APAC Cell and Gene Therapy Manufacturing Services Market Size Market Share by Type (2018-2023)
Table 31. APAC Cell and Gene Therapy Manufacturing Services Market Size by Application (2018-2023) & ($ Millions)
Table 32. APAC Cell and Gene Therapy Manufacturing Services Market Size Market Share by Application (2018-2023)
Table 33. Europe Cell and Gene Therapy Manufacturing Services Market Size by Country (2018-2023) & ($ Millions)
Table 34. Europe Cell and Gene Therapy Manufacturing Services Market Size Market Share by Country (2018-2023)
Table 35. Europe Cell and Gene Therapy Manufacturing Services Market Size by Type (2018-2023) & ($ Millions)
Table 36. Europe Cell and Gene Therapy Manufacturing Services Market Size Market Share by Type (2018-2023)
Table 37. Europe Cell and Gene Therapy Manufacturing Services Market Size by Application (2018-2023) & ($ Millions)
Table 38. Europe Cell and Gene Therapy Manufacturing Services Market Size Market Share by Application (2018-2023)
Table 39. Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Size by Region (2018-2023) & ($ Millions)
Table 40. Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Size Market Share by Region (2018-2023)
Table 41. Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Size by Type (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Size Market Share by Type (2018-2023)
Table 43. Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Size by Application (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Size Market Share by Application (2018-2023)
Table 45. Key Market Drivers & Growth Opportunities of Cell and Gene Therapy Manufacturing Services
Table 46. Key Market Challenges & Risks of Cell and Gene Therapy Manufacturing Services
Table 47. Key Industry Trends of Cell and Gene Therapy Manufacturing Services
Table 48. Global Cell and Gene Therapy Manufacturing Services Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 49. Global Cell and Gene Therapy Manufacturing Services Market Size Market Share Forecast by Regions (2024-2029)
Table 50. Global Cell and Gene Therapy Manufacturing Services Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 51. Global Cell and Gene Therapy Manufacturing Services Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 52. Thermo Fisher Scientific Details, Company Type, Cell and Gene Therapy Manufacturing Services Area Served and Its Competitors
Table 53. Thermo Fisher Scientific Cell and Gene Therapy Manufacturing Services Product Offered
Table 54. Thermo Fisher Scientific Cell and Gene Therapy Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 55. Thermo Fisher Scientific Main Business
Table 56. Thermo Fisher Scientific Latest Developments
Table 57. Merck KGaA Details, Company Type, Cell and Gene Therapy Manufacturing Services Area Served and Its Competitors
Table 58. Merck KGaA Cell and Gene Therapy Manufacturing Services Product Offered
Table 59. Merck KGaA Main Business
Table 60. Merck KGaA Cell and Gene Therapy Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 61. Merck KGaA Latest Developments
Table 62. Charles River Laboratories Details, Company Type, Cell and Gene Therapy Manufacturing Services Area Served and Its Competitors
Table 63. Charles River Laboratories Cell and Gene Therapy Manufacturing Services Product Offered
Table 64. Charles River Laboratories Main Business
Table 65. Charles River Laboratories Cell and Gene Therapy Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. Charles River Laboratories Latest Developments
Table 67. Lonza Details, Company Type, Cell and Gene Therapy Manufacturing Services Area Served and Its Competitors
Table 68. Lonza Cell and Gene Therapy Manufacturing Services Product Offered
Table 69. Lonza Main Business
Table 70. Lonza Cell and Gene Therapy Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. Lonza Latest Developments
Table 72. Catalent Details, Company Type, Cell and Gene Therapy Manufacturing Services Area Served and Its Competitors
Table 73. Catalent Cell and Gene Therapy Manufacturing Services Product Offered
Table 74. Catalent Main Business
Table 75. Catalent Cell and Gene Therapy Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 76. Catalent Latest Developments
Table 77. WuXi AppTec Details, Company Type, Cell and Gene Therapy Manufacturing Services Area Served and Its Competitors
Table 78. WuXi AppTec Cell and Gene Therapy Manufacturing Services Product Offered
Table 79. WuXi AppTec Main Business
Table 80. WuXi AppTec Cell and Gene Therapy Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 81. WuXi AppTec Latest Developments
Table 82. Takara Bio Inc Details, Company Type, Cell and Gene Therapy Manufacturing Services Area Served and Its Competitors
Table 83. Takara Bio Inc Cell and Gene Therapy Manufacturing Services Product Offered
Table 84. Takara Bio Inc Main Business
Table 85. Takara Bio Inc Cell and Gene Therapy Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 86. Takara Bio Inc Latest Developments
Table 87. Nikon Corporation Details, Company Type, Cell and Gene Therapy Manufacturing Services Area Served and Its Competitors
Table 88. Nikon Corporation Cell and Gene Therapy Manufacturing Services Product Offered
Table 89. Nikon Corporation Main Business
Table 90. Nikon Corporation Cell and Gene Therapy Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 91. Nikon Corporation Latest Developments
Table 92. FUJIFILM Holdings Corporation Details, Company Type, Cell and Gene Therapy Manufacturing Services Area Served and Its Competitors
Table 93. FUJIFILM Holdings Corporation Cell and Gene Therapy Manufacturing Services Product Offered
Table 94. FUJIFILM Holdings Corporation Main Business
Table 95. FUJIFILM Holdings Corporation Cell and Gene Therapy Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 96. FUJIFILM Holdings Corporation Latest Developments
Table 97. F. Hoffmann-La Roche Details, Company Type, Cell and Gene Therapy Manufacturing Services Area Served and Its Competitors
Table 98. F. Hoffmann-La Roche Cell and Gene Therapy Manufacturing Services Product Offered
Table 99. F. Hoffmann-La Roche Main Business
Table 100. F. Hoffmann-La Roche Cell and Gene Therapy Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 101. F. Hoffmann-La Roche Latest Developments
Table 102. Oxford Biomedica Plc Details, Company Type, Cell and Gene Therapy Manufacturing Services Area Served and Its Competitors
Table 103. Oxford Biomedica Plc Cell and Gene Therapy Manufacturing Services Product Offered
Table 104. Oxford Biomedica Plc Cell and Gene Therapy Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 105. Oxford Biomedica Plc Main Business
Table 106. Oxford Biomedica Plc Latest Developments
Table 107. Cell and Gene Therapy Catapult Details, Company Type, Cell and Gene Therapy Manufacturing Services Area Served and Its Competitors
Table 108. Cell and Gene Therapy Catapult Cell and Gene Therapy Manufacturing Services Product Offered
Table 109. Cell and Gene Therapy Catapult Main Business
Table 110. Cell and Gene Therapy Catapult Cell and Gene Therapy Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 111. Cell and Gene Therapy Catapult Latest Developments
Table 112. The Discovery Labs LLC Details, Company Type, Cell and Gene Therapy Manufacturing Services Area Served and Its Competitors
Table 113. The Discovery Labs LLC Cell and Gene Therapy Manufacturing Services Product Offered
Table 114. The Discovery Labs LLC Main Business
Table 115. The Discovery Labs LLC Cell and Gene Therapy Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 116. The Discovery Labs LLC Latest Developments
Table 117. RoslinCT Details, Company Type, Cell and Gene Therapy Manufacturing Services Area Served and Its Competitors
Table 118. RoslinCT Cell and Gene Therapy Manufacturing Services Product Offered
Table 119. RoslinCT Main Business
Table 120. RoslinCT Cell and Gene Therapy Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 121. RoslinCT Latest Developments
Table 122. JRS PHARMA Details, Company Type, Cell and Gene Therapy Manufacturing Services Area Served and Its Competitors
Table 123. JRS PHARMA Cell and Gene Therapy Manufacturing Services Product Offered
Table 124. JRS PHARMA Main Business
Table 125. JRS PHARMA Cell and Gene Therapy Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 126. JRS PHARMA Latest Developments
Table 127. FinVector Details, Company Type, Cell and Gene Therapy Manufacturing Services Area Served and Its Competitors
Table 128. FinVector Cell and Gene Therapy Manufacturing Services Product Offered
Table 129. FinVector Main Business
Table 130. FinVector Cell and Gene Therapy Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 131. FinVector Latest Developments
Table 132. ABL Details, Company Type, Cell and Gene Therapy Manufacturing Services Area Served and Its Competitors
Table 133. ABL Cell and Gene Therapy Manufacturing Services Product Offered
Table 134. ABL Main Business
Table 135. ABL Cell and Gene Therapy Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 136. ABL Latest Developments
Table 137. Resilience Details, Company Type, Cell and Gene Therapy Manufacturing Services Area Served and Its Competitors
Table 138. Resilience Cell and Gene Therapy Manufacturing Services Product Offered
Table 139. Resilience Main Business
Table 140. Resilience Cell and Gene Therapy Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 141. Resilience Latest Developments
Table 142. BioCentriq Details, Company Type, Cell and Gene Therapy Manufacturing Services Area Served and Its Competitors
Table 143. BioCentriq Cell and Gene Therapy Manufacturing Services Product Offered
Table 144. BioCentriq Main Business
Table 145. BioCentriq Cell and Gene Therapy Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 146. BioCentriq Latest Developments
Table 147. Porton Biopharma Limited Details, Company Type, Cell and Gene Therapy Manufacturing Services Area Served and Its Competitors
Table 148. Porton Biopharma Limited Cell and Gene Therapy Manufacturing Services Product Offered
Table 149. Porton Biopharma Limited Main Business
Table 150. Porton Biopharma Limited Cell and Gene Therapy Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 151. Porton Biopharma Limited Latest Developments
Table 152. Andelyn Biosciences Details, Company Type, Cell and Gene Therapy Manufacturing Services Area Served and Its Competitors
Table 153. Andelyn Biosciences Cell and Gene Therapy Manufacturing Services Product Offered
Table 154. Andelyn Biosciences Cell and Gene Therapy Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 155. Andelyn Biosciences Main Business
Table 156. Andelyn Biosciences Latest Developments
Table 157. Commercializing Living Therapies Details, Company Type, Cell and Gene Therapy Manufacturing Services Area Served and Its Competitors
Table 158. Commercializing Living Therapies Cell and Gene Therapy Manufacturing Services Product Offered
Table 159. Commercializing Living Therapies Main Business
Table 160. Commercializing Living Therapies Cell and Gene Therapy Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 161. Commercializing Living Therapies Latest Developments
Table 162. Vibalogics Details, Company Type, Cell and Gene Therapy Manufacturing Services Area Served and Its Competitors
Table 163. Vibalogics Cell and Gene Therapy Manufacturing Services Product Offered
Table 164. Vibalogics Main Business
Table 165. Vibalogics Cell and Gene Therapy Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 166. Vibalogics Latest Developments
Table 167. Anemocyte Srl Details, Company Type, Cell and Gene Therapy Manufacturing Services Area Served and Its Competitors
Table 168. Anemocyte Srl Cell and Gene Therapy Manufacturing Services Product Offered
Table 169. Anemocyte Srl Main Business
Table 170. Anemocyte Srl Cell and Gene Therapy Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 171. Anemocyte Srl Latest Developments
Table 172. ElevateBio Details, Company Type, Cell and Gene Therapy Manufacturing Services Area Served and Its Competitors
Table 173. ElevateBio Cell and Gene Therapy Manufacturing Services Product Offered
Table 174. ElevateBio Main Business
Table 175. ElevateBio Cell and Gene Therapy Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 176. ElevateBio Latest Developments
Table 1. Cell and Gene Therapy Manufacturing Services Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Allogeneic
Table 3. Major Players of Autologous
Table 4. Major Players of Viral Vector
Table 5. Cell and Gene Therapy Manufacturing Services Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 6. Global Cell and Gene Therapy Manufacturing Services Market Size by Type (2018-2023) & ($ Millions)
Table 7. Global Cell and Gene Therapy Manufacturing Services Market Size Market Share by Type (2018-2023)
Table 8. Cell and Gene Therapy Manufacturing Services Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global Cell and Gene Therapy Manufacturing Services Market Size by Application (2018-2023) & ($ Millions)
Table 10. Global Cell and Gene Therapy Manufacturing Services Market Size Market Share by Application (2018-2023)
Table 11. Global Cell and Gene Therapy Manufacturing Services Revenue by Players (2018-2023) & ($ Millions)
Table 12. Global Cell and Gene Therapy Manufacturing Services Revenue Market Share by Player (2018-2023)
Table 13. Cell and Gene Therapy Manufacturing Services Key Players Head office and Products Offered
Table 14. Cell and Gene Therapy Manufacturing Services Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Cell and Gene Therapy Manufacturing Services Market Size by Regions 2018-2023 & ($ Millions)
Table 18. Global Cell and Gene Therapy Manufacturing Services Market Size Market Share by Regions (2018-2023)
Table 19. Global Cell and Gene Therapy Manufacturing Services Revenue by Country/Region (2018-2023) & ($ millions)
Table 20. Global Cell and Gene Therapy Manufacturing Services Revenue Market Share by Country/Region (2018-2023)
Table 21. Americas Cell and Gene Therapy Manufacturing Services Market Size by Country (2018-2023) & ($ Millions)
Table 22. Americas Cell and Gene Therapy Manufacturing Services Market Size Market Share by Country (2018-2023)
Table 23. Americas Cell and Gene Therapy Manufacturing Services Market Size by Type (2018-2023) & ($ Millions)
Table 24. Americas Cell and Gene Therapy Manufacturing Services Market Size Market Share by Type (2018-2023)
Table 25. Americas Cell and Gene Therapy Manufacturing Services Market Size by Application (2018-2023) & ($ Millions)
Table 26. Americas Cell and Gene Therapy Manufacturing Services Market Size Market Share by Application (2018-2023)
Table 27. APAC Cell and Gene Therapy Manufacturing Services Market Size by Region (2018-2023) & ($ Millions)
Table 28. APAC Cell and Gene Therapy Manufacturing Services Market Size Market Share by Region (2018-2023)
Table 29. APAC Cell and Gene Therapy Manufacturing Services Market Size by Type (2018-2023) & ($ Millions)
Table 30. APAC Cell and Gene Therapy Manufacturing Services Market Size Market Share by Type (2018-2023)
Table 31. APAC Cell and Gene Therapy Manufacturing Services Market Size by Application (2018-2023) & ($ Millions)
Table 32. APAC Cell and Gene Therapy Manufacturing Services Market Size Market Share by Application (2018-2023)
Table 33. Europe Cell and Gene Therapy Manufacturing Services Market Size by Country (2018-2023) & ($ Millions)
Table 34. Europe Cell and Gene Therapy Manufacturing Services Market Size Market Share by Country (2018-2023)
Table 35. Europe Cell and Gene Therapy Manufacturing Services Market Size by Type (2018-2023) & ($ Millions)
Table 36. Europe Cell and Gene Therapy Manufacturing Services Market Size Market Share by Type (2018-2023)
Table 37. Europe Cell and Gene Therapy Manufacturing Services Market Size by Application (2018-2023) & ($ Millions)
Table 38. Europe Cell and Gene Therapy Manufacturing Services Market Size Market Share by Application (2018-2023)
Table 39. Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Size by Region (2018-2023) & ($ Millions)
Table 40. Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Size Market Share by Region (2018-2023)
Table 41. Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Size by Type (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Size Market Share by Type (2018-2023)
Table 43. Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Size by Application (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Size Market Share by Application (2018-2023)
Table 45. Key Market Drivers & Growth Opportunities of Cell and Gene Therapy Manufacturing Services
Table 46. Key Market Challenges & Risks of Cell and Gene Therapy Manufacturing Services
Table 47. Key Industry Trends of Cell and Gene Therapy Manufacturing Services
Table 48. Global Cell and Gene Therapy Manufacturing Services Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 49. Global Cell and Gene Therapy Manufacturing Services Market Size Market Share Forecast by Regions (2024-2029)
Table 50. Global Cell and Gene Therapy Manufacturing Services Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 51. Global Cell and Gene Therapy Manufacturing Services Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 52. Thermo Fisher Scientific Details, Company Type, Cell and Gene Therapy Manufacturing Services Area Served and Its Competitors
Table 53. Thermo Fisher Scientific Cell and Gene Therapy Manufacturing Services Product Offered
Table 54. Thermo Fisher Scientific Cell and Gene Therapy Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 55. Thermo Fisher Scientific Main Business
Table 56. Thermo Fisher Scientific Latest Developments
Table 57. Merck KGaA Details, Company Type, Cell and Gene Therapy Manufacturing Services Area Served and Its Competitors
Table 58. Merck KGaA Cell and Gene Therapy Manufacturing Services Product Offered
Table 59. Merck KGaA Main Business
Table 60. Merck KGaA Cell and Gene Therapy Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 61. Merck KGaA Latest Developments
Table 62. Charles River Laboratories Details, Company Type, Cell and Gene Therapy Manufacturing Services Area Served and Its Competitors
Table 63. Charles River Laboratories Cell and Gene Therapy Manufacturing Services Product Offered
Table 64. Charles River Laboratories Main Business
Table 65. Charles River Laboratories Cell and Gene Therapy Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. Charles River Laboratories Latest Developments
Table 67. Lonza Details, Company Type, Cell and Gene Therapy Manufacturing Services Area Served and Its Competitors
Table 68. Lonza Cell and Gene Therapy Manufacturing Services Product Offered
Table 69. Lonza Main Business
Table 70. Lonza Cell and Gene Therapy Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. Lonza Latest Developments
Table 72. Catalent Details, Company Type, Cell and Gene Therapy Manufacturing Services Area Served and Its Competitors
Table 73. Catalent Cell and Gene Therapy Manufacturing Services Product Offered
Table 74. Catalent Main Business
Table 75. Catalent Cell and Gene Therapy Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 76. Catalent Latest Developments
Table 77. WuXi AppTec Details, Company Type, Cell and Gene Therapy Manufacturing Services Area Served and Its Competitors
Table 78. WuXi AppTec Cell and Gene Therapy Manufacturing Services Product Offered
Table 79. WuXi AppTec Main Business
Table 80. WuXi AppTec Cell and Gene Therapy Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 81. WuXi AppTec Latest Developments
Table 82. Takara Bio Inc Details, Company Type, Cell and Gene Therapy Manufacturing Services Area Served and Its Competitors
Table 83. Takara Bio Inc Cell and Gene Therapy Manufacturing Services Product Offered
Table 84. Takara Bio Inc Main Business
Table 85. Takara Bio Inc Cell and Gene Therapy Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 86. Takara Bio Inc Latest Developments
Table 87. Nikon Corporation Details, Company Type, Cell and Gene Therapy Manufacturing Services Area Served and Its Competitors
Table 88. Nikon Corporation Cell and Gene Therapy Manufacturing Services Product Offered
Table 89. Nikon Corporation Main Business
Table 90. Nikon Corporation Cell and Gene Therapy Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 91. Nikon Corporation Latest Developments
Table 92. FUJIFILM Holdings Corporation Details, Company Type, Cell and Gene Therapy Manufacturing Services Area Served and Its Competitors
Table 93. FUJIFILM Holdings Corporation Cell and Gene Therapy Manufacturing Services Product Offered
Table 94. FUJIFILM Holdings Corporation Main Business
Table 95. FUJIFILM Holdings Corporation Cell and Gene Therapy Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 96. FUJIFILM Holdings Corporation Latest Developments
Table 97. F. Hoffmann-La Roche Details, Company Type, Cell and Gene Therapy Manufacturing Services Area Served and Its Competitors
Table 98. F. Hoffmann-La Roche Cell and Gene Therapy Manufacturing Services Product Offered
Table 99. F. Hoffmann-La Roche Main Business
Table 100. F. Hoffmann-La Roche Cell and Gene Therapy Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 101. F. Hoffmann-La Roche Latest Developments
Table 102. Oxford Biomedica Plc Details, Company Type, Cell and Gene Therapy Manufacturing Services Area Served and Its Competitors
Table 103. Oxford Biomedica Plc Cell and Gene Therapy Manufacturing Services Product Offered
Table 104. Oxford Biomedica Plc Cell and Gene Therapy Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 105. Oxford Biomedica Plc Main Business
Table 106. Oxford Biomedica Plc Latest Developments
Table 107. Cell and Gene Therapy Catapult Details, Company Type, Cell and Gene Therapy Manufacturing Services Area Served and Its Competitors
Table 108. Cell and Gene Therapy Catapult Cell and Gene Therapy Manufacturing Services Product Offered
Table 109. Cell and Gene Therapy Catapult Main Business
Table 110. Cell and Gene Therapy Catapult Cell and Gene Therapy Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 111. Cell and Gene Therapy Catapult Latest Developments
Table 112. The Discovery Labs LLC Details, Company Type, Cell and Gene Therapy Manufacturing Services Area Served and Its Competitors
Table 113. The Discovery Labs LLC Cell and Gene Therapy Manufacturing Services Product Offered
Table 114. The Discovery Labs LLC Main Business
Table 115. The Discovery Labs LLC Cell and Gene Therapy Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 116. The Discovery Labs LLC Latest Developments
Table 117. RoslinCT Details, Company Type, Cell and Gene Therapy Manufacturing Services Area Served and Its Competitors
Table 118. RoslinCT Cell and Gene Therapy Manufacturing Services Product Offered
Table 119. RoslinCT Main Business
Table 120. RoslinCT Cell and Gene Therapy Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 121. RoslinCT Latest Developments
Table 122. JRS PHARMA Details, Company Type, Cell and Gene Therapy Manufacturing Services Area Served and Its Competitors
Table 123. JRS PHARMA Cell and Gene Therapy Manufacturing Services Product Offered
Table 124. JRS PHARMA Main Business
Table 125. JRS PHARMA Cell and Gene Therapy Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 126. JRS PHARMA Latest Developments
Table 127. FinVector Details, Company Type, Cell and Gene Therapy Manufacturing Services Area Served and Its Competitors
Table 128. FinVector Cell and Gene Therapy Manufacturing Services Product Offered
Table 129. FinVector Main Business
Table 130. FinVector Cell and Gene Therapy Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 131. FinVector Latest Developments
Table 132. ABL Details, Company Type, Cell and Gene Therapy Manufacturing Services Area Served and Its Competitors
Table 133. ABL Cell and Gene Therapy Manufacturing Services Product Offered
Table 134. ABL Main Business
Table 135. ABL Cell and Gene Therapy Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 136. ABL Latest Developments
Table 137. Resilience Details, Company Type, Cell and Gene Therapy Manufacturing Services Area Served and Its Competitors
Table 138. Resilience Cell and Gene Therapy Manufacturing Services Product Offered
Table 139. Resilience Main Business
Table 140. Resilience Cell and Gene Therapy Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 141. Resilience Latest Developments
Table 142. BioCentriq Details, Company Type, Cell and Gene Therapy Manufacturing Services Area Served and Its Competitors
Table 143. BioCentriq Cell and Gene Therapy Manufacturing Services Product Offered
Table 144. BioCentriq Main Business
Table 145. BioCentriq Cell and Gene Therapy Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 146. BioCentriq Latest Developments
Table 147. Porton Biopharma Limited Details, Company Type, Cell and Gene Therapy Manufacturing Services Area Served and Its Competitors
Table 148. Porton Biopharma Limited Cell and Gene Therapy Manufacturing Services Product Offered
Table 149. Porton Biopharma Limited Main Business
Table 150. Porton Biopharma Limited Cell and Gene Therapy Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 151. Porton Biopharma Limited Latest Developments
Table 152. Andelyn Biosciences Details, Company Type, Cell and Gene Therapy Manufacturing Services Area Served and Its Competitors
Table 153. Andelyn Biosciences Cell and Gene Therapy Manufacturing Services Product Offered
Table 154. Andelyn Biosciences Cell and Gene Therapy Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 155. Andelyn Biosciences Main Business
Table 156. Andelyn Biosciences Latest Developments
Table 157. Commercializing Living Therapies Details, Company Type, Cell and Gene Therapy Manufacturing Services Area Served and Its Competitors
Table 158. Commercializing Living Therapies Cell and Gene Therapy Manufacturing Services Product Offered
Table 159. Commercializing Living Therapies Main Business
Table 160. Commercializing Living Therapies Cell and Gene Therapy Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 161. Commercializing Living Therapies Latest Developments
Table 162. Vibalogics Details, Company Type, Cell and Gene Therapy Manufacturing Services Area Served and Its Competitors
Table 163. Vibalogics Cell and Gene Therapy Manufacturing Services Product Offered
Table 164. Vibalogics Main Business
Table 165. Vibalogics Cell and Gene Therapy Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 166. Vibalogics Latest Developments
Table 167. Anemocyte Srl Details, Company Type, Cell and Gene Therapy Manufacturing Services Area Served and Its Competitors
Table 168. Anemocyte Srl Cell and Gene Therapy Manufacturing Services Product Offered
Table 169. Anemocyte Srl Main Business
Table 170. Anemocyte Srl Cell and Gene Therapy Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 171. Anemocyte Srl Latest Developments
Table 172. ElevateBio Details, Company Type, Cell and Gene Therapy Manufacturing Services Area Served and Its Competitors
Table 173. ElevateBio Cell and Gene Therapy Manufacturing Services Product Offered
Table 174. ElevateBio Main Business
Table 175. ElevateBio Cell and Gene Therapy Manufacturing Services Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 176. ElevateBio Latest Developments
LIST OF FIGURES
Figure 1. Cell and Gene Therapy Manufacturing Services Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Cell and Gene Therapy Manufacturing Services Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Cell and Gene Therapy Manufacturing Services Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Cell and Gene Therapy Manufacturing Services Sales Market Share by Country/Region (2022)
Figure 8. Cell and Gene Therapy Manufacturing Services Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Cell and Gene Therapy Manufacturing Services Market Size Market Share by Type in 2022
Figure 10. Cell and Gene Therapy Manufacturing Services in Oncology Diseases
Figure 11. Global Cell and Gene Therapy Manufacturing Services Market: Oncology Diseases (2018-2023) & ($ Millions)
Figure 12. Cell and Gene Therapy Manufacturing Services in Cardiovascular Diseases
Figure 13. Global Cell and Gene Therapy Manufacturing Services Market: Cardiovascular Diseases (2018-2023) & ($ Millions)
Figure 14. Cell and Gene Therapy Manufacturing Services in Orthopedic Diseases
Figure 15. Global Cell and Gene Therapy Manufacturing Services Market: Orthopedic Diseases (2018-2023) & ($ Millions)
Figure 16. Cell and Gene Therapy Manufacturing Services in Ophthalmology Diseases
Figure 17. Global Cell and Gene Therapy Manufacturing Services Market: Ophthalmology Diseases (2018-2023) & ($ Millions)
Figure 18. Cell and Gene Therapy Manufacturing Services in Infectious Diseases
Figure 19. Global Cell and Gene Therapy Manufacturing Services Market: Infectious Diseases (2018-2023) & ($ Millions)
Figure 20. Cell and Gene Therapy Manufacturing Services in Others
Figure 21. Global Cell and Gene Therapy Manufacturing Services Market: Others (2018-2023) & ($ Millions)
Figure 22. Global Cell and Gene Therapy Manufacturing Services Market Size Market Share by Application in 2022
Figure 23. Global Cell and Gene Therapy Manufacturing Services Revenue Market Share by Player in 2022
Figure 24. Global Cell and Gene Therapy Manufacturing Services Market Size Market Share by Regions (2018-2023)
Figure 25. Americas Cell and Gene Therapy Manufacturing Services Market Size 2018-2023 ($ Millions)
Figure 26. APAC Cell and Gene Therapy Manufacturing Services Market Size 2018-2023 ($ Millions)
Figure 27. Europe Cell and Gene Therapy Manufacturing Services Market Size 2018-2023 ($ Millions)
Figure 28. Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Size 2018-2023 ($ Millions)
Figure 29. Americas Cell and Gene Therapy Manufacturing Services Value Market Share by Country in 2022
Figure 30. United States Cell and Gene Therapy Manufacturing Services Market Size Growth 2018-2023 ($ Millions)
Figure 31. Canada Cell and Gene Therapy Manufacturing Services Market Size Growth 2018-2023 ($ Millions)
Figure 32. Mexico Cell and Gene Therapy Manufacturing Services Market Size Growth 2018-2023 ($ Millions)
Figure 33. Brazil Cell and Gene Therapy Manufacturing Services Market Size Growth 2018-2023 ($ Millions)
Figure 34. APAC Cell and Gene Therapy Manufacturing Services Market Size Market Share by Region in 2022
Figure 35. APAC Cell and Gene Therapy Manufacturing Services Market Size Market Share by Type in 2022
Figure 36. APAC Cell and Gene Therapy Manufacturing Services Market Size Market Share by Application in 2022
Figure 37. China Cell and Gene Therapy Manufacturing Services Market Size Growth 2018-2023 ($ Millions)
Figure 38. Japan Cell and Gene Therapy Manufacturing Services Market Size Growth 2018-2023 ($ Millions)
Figure 39. Korea Cell and Gene Therapy Manufacturing Services Market Size Growth 2018-2023 ($ Millions)
Figure 40. Southeast Asia Cell and Gene Therapy Manufacturing Services Market Size Growth 2018-2023 ($ Millions)
Figure 41. India Cell and Gene Therapy Manufacturing Services Market Size Growth 2018-2023 ($ Millions)
Figure 42. Australia Cell and Gene Therapy Manufacturing Services Market Size Growth 2018-2023 ($ Millions)
Figure 43. Europe Cell and Gene Therapy Manufacturing Services Market Size Market Share by Country in 2022
Figure 44. Europe Cell and Gene Therapy Manufacturing Services Market Size Market Share by Type (2018-2023)
Figure 45. Europe Cell and Gene Therapy Manufacturing Services Market Size Market Share by Application (2018-2023)
Figure 46. Germany Cell and Gene Therapy Manufacturing Services Market Size Growth 2018-2023 ($ Millions)
Figure 47. France Cell and Gene Therapy Manufacturing Services Market Size Growth 2018-2023 ($ Millions)
Figure 48. UK Cell and Gene Therapy Manufacturing Services Market Size Growth 2018-2023 ($ Millions)
Figure 49. Italy Cell and Gene Therapy Manufacturing Services Market Size Growth 2018-2023 ($ Millions)
Figure 50. Russia Cell and Gene Therapy Manufacturing Services Market Size Growth 2018-2023 ($ Millions)
Figure 51. Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Size Market Share by Region (2018-2023)
Figure 52. Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Size Market Share by Type (2018-2023)
Figure 53. Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Size Market Share by Application (2018-2023)
Figure 54. Egypt Cell and Gene Therapy Manufacturing Services Market Size Growth 2018-2023 ($ Millions)
Figure 55. South Africa Cell and Gene Therapy Manufacturing Services Market Size Growth 2018-2023 ($ Millions)
Figure 56. Israel Cell and Gene Therapy Manufacturing Services Market Size Growth 2018-2023 ($ Millions)
Figure 57. Turkey Cell and Gene Therapy Manufacturing Services Market Size Growth 2018-2023 ($ Millions)
Figure 58. GCC Country Cell and Gene Therapy Manufacturing Services Market Size Growth 2018-2023 ($ Millions)
Figure 59. Americas Cell and Gene Therapy Manufacturing Services Market Size 2024-2029 ($ Millions)
Figure 60. APAC Cell and Gene Therapy Manufacturing Services Market Size 2024-2029 ($ Millions)
Figure 61. Europe Cell and Gene Therapy Manufacturing Services Market Size 2024-2029 ($ Millions)
Figure 62. Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Size 2024-2029 ($ Millions)
Figure 63. United States Cell and Gene Therapy Manufacturing Services Market Size 2024-2029 ($ Millions)
Figure 64. Canada Cell and Gene Therapy Manufacturing Services Market Size 2024-2029 ($ Millions)
Figure 65. Mexico Cell and Gene Therapy Manufacturing Services Market Size 2024-2029 ($ Millions)
Figure 66. Brazil Cell and Gene Therapy Manufacturing Services Market Size 2024-2029 ($ Millions)
Figure 67. China Cell and Gene Therapy Manufacturing Services Market Size 2024-2029 ($ Millions)
Figure 68. Japan Cell and Gene Therapy Manufacturing Services Market Size 2024-2029 ($ Millions)
Figure 69. Korea Cell and Gene Therapy Manufacturing Services Market Size 2024-2029 ($ Millions)
Figure 70. Southeast Asia Cell and Gene Therapy Manufacturing Services Market Size 2024-2029 ($ Millions)
Figure 71. India Cell and Gene Therapy Manufacturing Services Market Size 2024-2029 ($ Millions)
Figure 72. Australia Cell and Gene Therapy Manufacturing Services Market Size 2024-2029 ($ Millions)
Figure 73. Germany Cell and Gene Therapy Manufacturing Services Market Size 2024-2029 ($ Millions)
Figure 74. France Cell and Gene Therapy Manufacturing Services Market Size 2024-2029 ($ Millions)
Figure 75. UK Cell and Gene Therapy Manufacturing Services Market Size 2024-2029 ($ Millions)
Figure 76. Italy Cell and Gene Therapy Manufacturing Services Market Size 2024-2029 ($ Millions)
Figure 77. Russia Cell and Gene Therapy Manufacturing Services Market Size 2024-2029 ($ Millions)
Figure 78. Spain Cell and Gene Therapy Manufacturing Services Market Size 2024-2029 ($ Millions)
Figure 79. Egypt Cell and Gene Therapy Manufacturing Services Market Size 2024-2029 ($ Millions)
Figure 80. South Africa Cell and Gene Therapy Manufacturing Services Market Size 2024-2029 ($ Millions)
Figure 81. Israel Cell and Gene Therapy Manufacturing Services Market Size 2024-2029 ($ Millions)
Figure 82. Turkey Cell and Gene Therapy Manufacturing Services Market Size 2024-2029 ($ Millions)
Figure 83. GCC Countries Cell and Gene Therapy Manufacturing Services Market Size 2024-2029 ($ Millions)
Figure 84. Global Cell and Gene Therapy Manufacturing Services Market Size Market Share Forecast by Type (2024-2029)
Figure 85. Global Cell and Gene Therapy Manufacturing Services Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Cell and Gene Therapy Manufacturing Services Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Cell and Gene Therapy Manufacturing Services Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Cell and Gene Therapy Manufacturing Services Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Cell and Gene Therapy Manufacturing Services Sales Market Share by Country/Region (2022)
Figure 8. Cell and Gene Therapy Manufacturing Services Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Cell and Gene Therapy Manufacturing Services Market Size Market Share by Type in 2022
Figure 10. Cell and Gene Therapy Manufacturing Services in Oncology Diseases
Figure 11. Global Cell and Gene Therapy Manufacturing Services Market: Oncology Diseases (2018-2023) & ($ Millions)
Figure 12. Cell and Gene Therapy Manufacturing Services in Cardiovascular Diseases
Figure 13. Global Cell and Gene Therapy Manufacturing Services Market: Cardiovascular Diseases (2018-2023) & ($ Millions)
Figure 14. Cell and Gene Therapy Manufacturing Services in Orthopedic Diseases
Figure 15. Global Cell and Gene Therapy Manufacturing Services Market: Orthopedic Diseases (2018-2023) & ($ Millions)
Figure 16. Cell and Gene Therapy Manufacturing Services in Ophthalmology Diseases
Figure 17. Global Cell and Gene Therapy Manufacturing Services Market: Ophthalmology Diseases (2018-2023) & ($ Millions)
Figure 18. Cell and Gene Therapy Manufacturing Services in Infectious Diseases
Figure 19. Global Cell and Gene Therapy Manufacturing Services Market: Infectious Diseases (2018-2023) & ($ Millions)
Figure 20. Cell and Gene Therapy Manufacturing Services in Others
Figure 21. Global Cell and Gene Therapy Manufacturing Services Market: Others (2018-2023) & ($ Millions)
Figure 22. Global Cell and Gene Therapy Manufacturing Services Market Size Market Share by Application in 2022
Figure 23. Global Cell and Gene Therapy Manufacturing Services Revenue Market Share by Player in 2022
Figure 24. Global Cell and Gene Therapy Manufacturing Services Market Size Market Share by Regions (2018-2023)
Figure 25. Americas Cell and Gene Therapy Manufacturing Services Market Size 2018-2023 ($ Millions)
Figure 26. APAC Cell and Gene Therapy Manufacturing Services Market Size 2018-2023 ($ Millions)
Figure 27. Europe Cell and Gene Therapy Manufacturing Services Market Size 2018-2023 ($ Millions)
Figure 28. Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Size 2018-2023 ($ Millions)
Figure 29. Americas Cell and Gene Therapy Manufacturing Services Value Market Share by Country in 2022
Figure 30. United States Cell and Gene Therapy Manufacturing Services Market Size Growth 2018-2023 ($ Millions)
Figure 31. Canada Cell and Gene Therapy Manufacturing Services Market Size Growth 2018-2023 ($ Millions)
Figure 32. Mexico Cell and Gene Therapy Manufacturing Services Market Size Growth 2018-2023 ($ Millions)
Figure 33. Brazil Cell and Gene Therapy Manufacturing Services Market Size Growth 2018-2023 ($ Millions)
Figure 34. APAC Cell and Gene Therapy Manufacturing Services Market Size Market Share by Region in 2022
Figure 35. APAC Cell and Gene Therapy Manufacturing Services Market Size Market Share by Type in 2022
Figure 36. APAC Cell and Gene Therapy Manufacturing Services Market Size Market Share by Application in 2022
Figure 37. China Cell and Gene Therapy Manufacturing Services Market Size Growth 2018-2023 ($ Millions)
Figure 38. Japan Cell and Gene Therapy Manufacturing Services Market Size Growth 2018-2023 ($ Millions)
Figure 39. Korea Cell and Gene Therapy Manufacturing Services Market Size Growth 2018-2023 ($ Millions)
Figure 40. Southeast Asia Cell and Gene Therapy Manufacturing Services Market Size Growth 2018-2023 ($ Millions)
Figure 41. India Cell and Gene Therapy Manufacturing Services Market Size Growth 2018-2023 ($ Millions)
Figure 42. Australia Cell and Gene Therapy Manufacturing Services Market Size Growth 2018-2023 ($ Millions)
Figure 43. Europe Cell and Gene Therapy Manufacturing Services Market Size Market Share by Country in 2022
Figure 44. Europe Cell and Gene Therapy Manufacturing Services Market Size Market Share by Type (2018-2023)
Figure 45. Europe Cell and Gene Therapy Manufacturing Services Market Size Market Share by Application (2018-2023)
Figure 46. Germany Cell and Gene Therapy Manufacturing Services Market Size Growth 2018-2023 ($ Millions)
Figure 47. France Cell and Gene Therapy Manufacturing Services Market Size Growth 2018-2023 ($ Millions)
Figure 48. UK Cell and Gene Therapy Manufacturing Services Market Size Growth 2018-2023 ($ Millions)
Figure 49. Italy Cell and Gene Therapy Manufacturing Services Market Size Growth 2018-2023 ($ Millions)
Figure 50. Russia Cell and Gene Therapy Manufacturing Services Market Size Growth 2018-2023 ($ Millions)
Figure 51. Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Size Market Share by Region (2018-2023)
Figure 52. Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Size Market Share by Type (2018-2023)
Figure 53. Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Size Market Share by Application (2018-2023)
Figure 54. Egypt Cell and Gene Therapy Manufacturing Services Market Size Growth 2018-2023 ($ Millions)
Figure 55. South Africa Cell and Gene Therapy Manufacturing Services Market Size Growth 2018-2023 ($ Millions)
Figure 56. Israel Cell and Gene Therapy Manufacturing Services Market Size Growth 2018-2023 ($ Millions)
Figure 57. Turkey Cell and Gene Therapy Manufacturing Services Market Size Growth 2018-2023 ($ Millions)
Figure 58. GCC Country Cell and Gene Therapy Manufacturing Services Market Size Growth 2018-2023 ($ Millions)
Figure 59. Americas Cell and Gene Therapy Manufacturing Services Market Size 2024-2029 ($ Millions)
Figure 60. APAC Cell and Gene Therapy Manufacturing Services Market Size 2024-2029 ($ Millions)
Figure 61. Europe Cell and Gene Therapy Manufacturing Services Market Size 2024-2029 ($ Millions)
Figure 62. Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Size 2024-2029 ($ Millions)
Figure 63. United States Cell and Gene Therapy Manufacturing Services Market Size 2024-2029 ($ Millions)
Figure 64. Canada Cell and Gene Therapy Manufacturing Services Market Size 2024-2029 ($ Millions)
Figure 65. Mexico Cell and Gene Therapy Manufacturing Services Market Size 2024-2029 ($ Millions)
Figure 66. Brazil Cell and Gene Therapy Manufacturing Services Market Size 2024-2029 ($ Millions)
Figure 67. China Cell and Gene Therapy Manufacturing Services Market Size 2024-2029 ($ Millions)
Figure 68. Japan Cell and Gene Therapy Manufacturing Services Market Size 2024-2029 ($ Millions)
Figure 69. Korea Cell and Gene Therapy Manufacturing Services Market Size 2024-2029 ($ Millions)
Figure 70. Southeast Asia Cell and Gene Therapy Manufacturing Services Market Size 2024-2029 ($ Millions)
Figure 71. India Cell and Gene Therapy Manufacturing Services Market Size 2024-2029 ($ Millions)
Figure 72. Australia Cell and Gene Therapy Manufacturing Services Market Size 2024-2029 ($ Millions)
Figure 73. Germany Cell and Gene Therapy Manufacturing Services Market Size 2024-2029 ($ Millions)
Figure 74. France Cell and Gene Therapy Manufacturing Services Market Size 2024-2029 ($ Millions)
Figure 75. UK Cell and Gene Therapy Manufacturing Services Market Size 2024-2029 ($ Millions)
Figure 76. Italy Cell and Gene Therapy Manufacturing Services Market Size 2024-2029 ($ Millions)
Figure 77. Russia Cell and Gene Therapy Manufacturing Services Market Size 2024-2029 ($ Millions)
Figure 78. Spain Cell and Gene Therapy Manufacturing Services Market Size 2024-2029 ($ Millions)
Figure 79. Egypt Cell and Gene Therapy Manufacturing Services Market Size 2024-2029 ($ Millions)
Figure 80. South Africa Cell and Gene Therapy Manufacturing Services Market Size 2024-2029 ($ Millions)
Figure 81. Israel Cell and Gene Therapy Manufacturing Services Market Size 2024-2029 ($ Millions)
Figure 82. Turkey Cell and Gene Therapy Manufacturing Services Market Size 2024-2029 ($ Millions)
Figure 83. GCC Countries Cell and Gene Therapy Manufacturing Services Market Size 2024-2029 ($ Millions)
Figure 84. Global Cell and Gene Therapy Manufacturing Services Market Size Market Share Forecast by Type (2024-2029)
Figure 85. Global Cell and Gene Therapy Manufacturing Services Market Size Market Share Forecast by Application (2024-2029)
